These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34584902)

  • 21. Demographic and Clinical Characteristics of Persons with HIV with Viral Load:Adherence Mismatch Who Are at Risk of Future Viremia.
    Grinsteiner E; Morrow M; Mawhinney S; Coyle RP; Coleman SS; Zheng JH; Ellison L; Bushman LR; Kiser JJ; Anderson PL; Castillo-Mancilla JR
    AIDS Res Hum Retroviruses; 2023 Jan; 39(1):33-37. PubMed ID: 36301917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short Communication: Cascade of Antiretroviral Therapy Adherence in Virologically Suppressed Persons Living with HIV.
    Castillo-Mancilla JR; Coyle RP; Coleman SS; Morrow M; Gardner EM; Zheng JH; Ellison L; Bushman LR; Kiser JJ; MaWhinney S; Anderson PL
    AIDS Res Hum Retroviruses; 2020 Mar; 36(3):173-175. PubMed ID: 31204866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with tenofovir diphosphate concentrations in dried blood spots in persons living with HIV.
    Coyle RP; Morrow M; Coleman SS; Gardner EM; Zheng JH; Ellison L; Bushman LR; Kiser JJ; MaWhinney S; Anderson PL; Castillo-Mancilla JR
    J Antimicrob Chemother; 2020 Jun; 75(6):1591-1598. PubMed ID: 32211787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower Cumulative Antiretroviral Exposure in People Living With HIV and Diabetes Mellitus.
    Mann SC; Morrow M; Coyle RP; Coleman SS; Saderup A; Zheng JH; Ellison L; Bushman LR; Kiser JJ; MaWhinney S; Anderson PL; Castillo-Mancilla JR
    J Acquir Immune Defic Syndr; 2020 Dec; 85(4):483-488. PubMed ID: 33136749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engagement in Mental Health Care is Associated with Higher Cumulative Drug Exposure and Adherence to Antiretroviral Therapy.
    Coyle RP; Schneck CD; Morrow M; Coleman SS; Gardner EM; Zheng JH; Ellison L; Bushman LR; Kiser JJ; Mawhinney S; Anderson PL; Castillo-Mancilla JR
    AIDS Behav; 2019 Dec; 23(12):3493-3502. PubMed ID: 30798457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short Communication: Association of Vitamin D Insufficiency and Protective Tenofovir Diphosphate Concentrations with Bone Toxicity in Adolescent Boys and Young Men Using Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-Exposure Prophylaxis.
    Havens PL; Tamhane A; Stephensen CB; Schuster GU; Gordon CM; Liu N; Wilson CM; Hosek SG; Anderson PL; Kapogiannis BG; Mulligan K
    AIDS Res Hum Retroviruses; 2019 Feb; 35(2):123-128. PubMed ID: 30280906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy.
    Anderson PL; Liu AY; Castillo-Mancilla JR; Gardner EM; Seifert SM; McHugh C; Wagner T; Campbell K; Morrow M; Ibrahim M; Buchbinder S; Bushman LR; Kiser JJ; MaWhinney S
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis.
    Pyra M; Anderson PL; Hendrix CW; Heffron R; Mugwanya K; Haberer JE; Thomas KK; Celum C; Donnell D; Marzinke MA; Bukusi EA; Mugo NR; Asiimwe S; Katabira E; Baeten JM;
    AIDS; 2018 Aug; 32(13):1891-1898. PubMed ID: 29894385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment.
    Elvstam O; Medstrand P; Yilmaz A; Isberg PE; Gisslén M; Björkman P
    PLoS One; 2017; 12(7):e0180761. PubMed ID: 28683128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of virological failure in HIV-1-infected patients experiencing low-level viraemia under active antiretroviral therapy (ANRS C03 cohort study).
    Vandenhende MA; Perrier A; Bonnet F; Lazaro E; Cazanave C; Reigadas S; Chêne G; Morlat P;
    Antivir Ther; 2015; 20(6):655-60. PubMed ID: 25735799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Lymphoid Tissue Pharmacokinetics of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide in HIV-Infected Persons.
    Fletcher CV; Podany AT; Thorkelson A; Winchester LC; Mykris T; Anderson J; Jorstad S; Baker JV; Schacker TW
    Clin Pharmacol Ther; 2020 Nov; 108(5):971-975. PubMed ID: 32385902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Virus Viremia During Combination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study.
    Elvstam O; Marrone G; Medstrand P; Treutiger CJ; Sönnerborg A; Gisslén M; Björkman P
    Clin Infect Dis; 2021 Jun; 72(12):2079-2086. PubMed ID: 32271361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short Communication: A Descriptive Analysis of Dried Blood Spot Adherence Testing Among Ugandans with HIV Presenting with Cryptococcal Meningitis.
    Lofgren SM; Nicol MR; Kandole TK; Castillo-Mancilla J; Anderson PL; Mpoza E; Tugume L; Bangdiwala AS; Ssebambulidde K; Hullsiek KH; Rhein J; Meya DB; Boulware DR
    AIDS Res Hum Retroviruses; 2021 Jul; 37(7):529-533. PubMed ID: 33677986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation.
    Laprise C; de Pokomandy A; Baril JG; Dufresne S; Trottier H
    Clin Infect Dis; 2013 Nov; 57(10):1489-96. PubMed ID: 23946221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tenofovir-Diphosphate as a Marker of HIV Pre-exposure Prophylaxis Use Among East African Men and Women.
    Pyra M; Anderson P; Haberer JE; Heffron R; Celum C; Asiimwe S; Katabira E; Mugo NR; Bukusi EA; Baeten JM
    Front Pharmacol; 2019; 10():401. PubMed ID: 31057407
    [No Abstract]   [Full Text] [Related]  

  • 36. Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.
    Castillo-Mancilla J; Seifert S; Campbell K; Coleman S; McAllister K; Zheng JH; Gardner EM; Liu A; Glidden DV; Grant R; Hosek S; Wilson CM; Bushman LR; MaWhinney S; Anderson PL
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6692-6697. PubMed ID: 27572401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent Low-level Viremia While on Antiretroviral Therapy Is an Independent Risk Factor for Virologic Failure.
    Joya C; Won SH; Schofield C; Lalani T; Maves RC; Kronmann K; Deiss R; Okulicz J; Agan BK; Ganesan A
    Clin Infect Dis; 2019 Nov; 69(12):2145-2152. PubMed ID: 30785191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy.
    Fleming J; Mathews WC; Rutstein RM; Aberg J; Somboonwit C; Cheever LW; Berry SA; Gebo KA; Moore RD;
    AIDS; 2019 Nov; 33(13):2005-2012. PubMed ID: 31306175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tenofovir diphosphate and emtricitabine triphosphate concentrations in blood cells compared with isolated peripheral blood mononuclear cells: a new measure of antiretroviral adherence?
    Adams JL; Sykes C; Menezes P; Prince HM; Patterson KB; Fransen K; Crucitti T; De Baetselier I; Van Damme L; Kashuba AD
    J Acquir Immune Defic Syndr; 2013 Mar; 62(3):260-6. PubMed ID: 23111578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low Level Viremia Is Associated With Serious non-AIDS Events in People With HIV.
    Ganesan A; Hsieh HC; Chu X; Colombo RE; Berjohn C; Lalani T; Yabes J; Joya CA; Blaylock J; Agan BK
    Open Forum Infect Dis; 2024 Apr; 11(4):ofae147. PubMed ID: 38628953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.